We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$233M
2
WPC icon
W.P. Carey
WPC
+$93M
3
EXR icon
Extra Space Storage
EXR
+$81.4M
4
IRM icon
Iron Mountain
IRM
+$41.1M
5
EGP icon
EastGroup Properties
EGP
+$39.7M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$154M
2
KRMA
Global X Conscious Companies ETF
KRMA
+$114M
3
CUZ icon
Cousins Properties
CUZ
+$106M
4
FR icon
First Industrial Realty Trust
FR
+$66.7M
5
PSA icon
Public Storage
PSA
+$53.2M

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
1151
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
– –
GRFS
1152
Grifois
GRFS
$5.44B
$4K ﹤0.01%
398
– –
IOVA icon
1153
Iovance Biotherapeutics
IOVA
$2.1B
$4K ﹤0.01%
877
– –
KROS icon
1154
Keros Therapeutics
KROS
$199M
$4K ﹤0.01%
111
– –
LGND icon
1155
Ligand Pharmaceuticals
LGND
$5.94B
$4K ﹤0.01%
63
– –
MNKD icon
1156
MannKind Corp
MNKD
$1.21B
$4K ﹤0.01%
1,058
– –
MRUS
1157
DELISTED
Merus
MRUS
$4K ﹤0.01%
186
– –
RLAY icon
1158
Relay Therapeutics
RLAY
$3.99B
$4K ﹤0.01%
486
– –
SNDX icon
1159
Syndax Pharmaceuticals
SNDX
$1.74B
$4K ﹤0.01%
242
– –
TNGX icon
1160
Tango Therapeutics
TNGX
$4.34B
$4K ﹤0.01%
355
– –
TWST icon
1161
Twist Bioscience
TWST
$5.51B
$4K ﹤0.01%
210
– –
VRNA
1162
DELISTED
Verona Pharma
VRNA
$4K ﹤0.01%
244
– –
XNCR icon
1163
Xencor
XNCR
$1.48B
$4K ﹤0.01%
222
– –
ZNTL icon
1164
Zentalis Pharmaceuticals
ZNTL
$329M
$4K ﹤0.01%
212
– –
RVNC
1165
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
331
– –
MORF
1166
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4K ﹤0.01%
155
– –
EQRX
1167
DELISTED
EQRx, Inc. Common Stock
EQRX
$4K ﹤0.01%
1,964
– –
ADMA icon
1168
ADMA Biologics
ADMA
$2.04B
$3K ﹤0.01%
791
– –
ADPT icon
1169
Adaptive Biotechnologies
ADPT
$3.6B
$3K ﹤0.01%
530
– –
ARDX icon
1170
Ardelyx
ARDX
$1.25B
$3K ﹤0.01%
754
– –
AVDL
1171
DELISTED
Avadel Pharmaceuticals
AVDL
$3K ﹤0.01%
245
– –
CHGG icon
1172
PUT
Chegg
CHGG
$121M
$3K ﹤0.01%
3,000
– –
COGT icon
1173
Cogent Biosciences
COGT
$6.95B
$3K ﹤0.01%
281
– –
COLL icon
1174
Collegium Pharmaceutical
COLL
$1.16B
$3K ﹤0.01%
127
– –
ETNB
1175
DELISTED
89bio
ETNB
$3K ﹤0.01%
187
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.